InvestorsHub Logo
Replies to #59 on Replimune (REPL)

jondoeuk

10/05/21 9:03 PM

#60 RE: puravida #59

Looking forward to seeing these updates from SITC.



A number (three) will be TIP posters, so the only clinical update is going to be from the ongoing RP2 (+/- Opdivo) trial. It will be interesting to compare that to ONCR's ONCR-177 (initial clinical data also being presented at the same event), which uses a kitchen sink approach (the transgenes are Flt3L, IL-12, CCL4, anti-CTLA-4 and anti-PD-1, there are differences between the base viruses, but both use HSV-1).

Did MGMT slip up last year and release the abstract content with initial PR of SITC abstract titles? The PR on oct14 2020 included the abstract content and SITC embargo for abstract content unlocks right before the actual conference



No, it was the organisers, with data leaking via their site.

This year I think the abstract embargo lifts Nov 9 2021.



Yes, at 8 am EST.